Patent ID: 6825213
Filing Date: 2004-11-30
Classification: A61P,C07D

Abstract:
A compound having the structure: wherein:R1 and R3 are independently selected from the group consisting of hydrogen, halogen, alkyl, aryl alkyl, CF3, and OCH3; R2 is selected from the group consisting of hydrogen, halogen, OH, OCH3, OCH2COOH, C(O)-aryl, NCS, NH2, N3, NHR8, NHCH2COOH, NHCOR13, NHCONHR13, and NHCOSR13; R4 and R5 are each independently selected from the group consisting of hydrogen, OH, and halogen; R6 and R7 are each independently selected from the group consisting of hydrogen and halogen; R8 is selected from the group consisting of hydrogen, lower alkyl of from 1 to 8 carbons, halogen, OCH3, and CF3; and R13 is selected from the group consisting of hydrogen, lower alkyl of from 1 to 8 carbons, phenyl, halogen, OCH3, CF3, and â€”CH2Râ€², wherein Râ€² is halogen; wherein no more than one of R1, R2, and R3 is OCH3 or hydrogen and one, but not both, of R4 and R5 is OH; or a pharmaceutically acceptable salt thereof.